Lepu Biopharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	10,105	8,968	4,482	6,986	12,197	-
Market Cap Growth	75.29%	100.10%	-35.85%	-42.72%	-	-
Enterprise Value	10,189	9,348	4,671	7,196	11,782	-
Last Close Price	5.60	4.97	2.62	4.21	7.35	-
PE Ratio	33.55	30.83	-	-	-	-
PS Ratio	9.71	8.62	11.45	28.14	692.84	-
PB Ratio	6.66	5.91	6.18	7.14	11.98	-
P/TBV Ratio	10.26	9.10	15.74	13.71	23.98	-
EV/Sales Ratio	9.79	8.99	11.93	28.99	669.30	-
EV/EBITDA Ratio	25.45	22.87	-	-	-	-
EV/EBIT Ratio	32.98	29.46	-	-	-	-
Debt / Equity Ratio	0.78	0.78	1.25	0.84	0.77	0.40
Debt / EBITDA Ratio	2.88	2.88	-	-	-	-
Net Debt / Equity Ratio	0.07	0.07	0.55	0.28	0.01	0.14
Net Debt / EBITDA Ratio	0.27	0.27	-1.19	-0.81	-0.02	-0.14
Net Debt / FCF Ratio	-	-	-1.63	-0.89	-0.02	-0.14
Asset Turnover	0.35	0.35	0.16	0.09	0.01	-
Inventory Turnover	2.40	2.40	2.87	1.06	0.08	-
Quick Ratio	0.94	0.94	0.54	0.62	0.83	0.39
Current Ratio	0.98	0.98	0.62	0.75	0.96	0.57
Return on Equity (ROE)	25.32%	25.32%	-54.02%	-3.39%	-80.03%	-87.61%
Return on Assets (ROA)	6.62%	6.62%	-10.61%	-9.94%	-17.41%	-26.18%
Return on Invested Capital (ROIC)	19.37%	22.49%	-36.10%	-38.10%	-68.31%	-98.74%
Return on Capital Employed (ROCE)	14.70%	14.70%	-32.00%	-26.30%	-38.10%	-61.60%
Earnings Yield	2.88%	3.24%	-9.77%	-0.35%	-6.39%	-
FCF Yield	-	-	-5.45%	-4.40%	-5.48%	-
Buyback Yield / Dilution	-3.07%	-3.07%	-1.87%	-1.14%	-7.92%	-33.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.